High energy focused extracorporeal shock wave therapy for early and mid-stage femoral head necrosis: A single center retrospective cohort study
Original Article | Vol 3 | Issue 2 | July-December 2023 | page: 29-34 | Leilei Zhang, Xuanye Zhu, Haonan Ling, Ruimeng Duan, Ying Zhang, Youwen Liu, Xiantao Chen
DOI: https://doi.org/10.13107/jrs.2023.v03.i02.97
Author: Leilei Zhang [1, 2], Xuanye Zhu [2], Haonan Ling [1], Ruimeng Duan [1], Ying Zhang [1], Youwen Liu [1], Xiantao Chen [1]
[1] Center of hip Surgery, Henan Luoyang Orthopedic-Traumatological Hospital, Orthopedic Hospital of Henan Province, Luoyang, China.
[2] Henan University of Traditional Chinese Medicine, Zhengzhou, China.
Address of Correspondence
Dr. Youwen Liu and Xiantao Chen,
Medical Center of Hip Surgery, Henan Luoyang Orthopedic- Traumatological Hospital, Orthopedic Hospital of Henan Province, No. 82, South Qiming Road, 471002, Luoyang, China.
E-mail: luoyangzhenggu@139.com
Abstract
Background: Research has shown that extracorporeal shock wave therapy has a certain therapeutic effect on the osteonecrosis of the femoral head (ONFH). However, the sample sizes are relatively small. The aim of this study is to evaluate and investigate the clinical efficacy and safety of high-energy extracorporeal shock wave treatment (ESWT) in the management of early and mid-stage ONFH by observing a large size clinical sample.
Materials & Methods: 453 patients with stage I–III ONFH treated ESWT in our hospital between June 2019 to August 2021, are included. The visual analog pain scale (VAS), Harris hip score, radiography, and magnetic resonance imaging were used to estimate treatment results. The progression of ONFH was evaluated by imaging examination and clinical outcomes.
Results: The mean follow-up was 39.81±7.94 months (range 26 to 50 months). The mean VAS decreased from 5.54 ± 1.19 before ESWT treatment to 1.92 ± 0.43 points at the 12 months follow-up (p < 0.001). The mean Harris hip score improved from 75.51 ± 5.14 before ESWT treatment, to 92.21 ± 4.53 at the 12 months follow-up (p < 0.001). The clinical success(improvement) was observed in 85.71% of ARCO stage I patients, 48.09% of ARCO stage II patients, and 49.15% of ARCO stage III patients. Imaging success (no worsening of clinical images) was observed in 12.38% stage I hips, 28.37% of stage II hips, and 27.12% of stage III hips, respectively. The hip joint survival rate of stage Ⅱ and stage Ⅲ patients was 86.51% and 77.97% (P<0.05).
Conclusions: The result of the current study suggests that ESWT definitely represents an effective, reliable, and safe therapeutic method for early and middle stages of ONFH with bone marrow edema syndrome (BMES), and should be recommended as a therapeutic option.
Keywords: High-energy extracorporeal shock wave therapy, Osteonecrosis, Femoral head, Bone marrow edema.
References:
[1] Mont MA, Cherian JJ, Sierra RJ, et al. Nontraumatic osteonecrosis of the femoral head: where do we stand today? A ten-year update [J]. J Bone Joint Surg Am, 2015, 97:1604-1627.
[2] Zhao DW, Yu M, Hu K, et al. Prevalence of nontraumatic osteonecrosis of the femoral head and its associated risk factors in the chinese population: results from a nationally representative survey. Chin Med J (Engl), 2015, 128(21): 2843-2850.
[3] Mont Michael A,Salem Hytham S,Piuzzi Nicolas S,Goodman Stuart B,Jones Lynne C. Nontraumatic Osteonecrosis of the Femoral Head: Where Do We Stand Today?: A 5-Year Update.[J]. The Journal of bone and joint surgery. American volume,2020,102(12):1084-1099.
[4] Haupt G, Haupt A, Ekkernkamp A, et al. Influence of shock waves on fracture healing[J]. Urology, 1992, 39(6):529-532.
[5] Zhang, L, Cui, Y, Liang, D, et al. High-energy focused extracorporeal shock wave therapy for bone marrow edema syndrome of the hip: A retrospective study. MEDICINE. 2020; 99 (16): e19747.
[6] Wang CJ, Chou WY, Hsu SL, et al. ESWT and alendronate sodium demonstrate equal protective effects in osteoarthritis of the knee [J].ShockWaves, 2016, 26(1):53-62.
[7] Kai,Xie,Yuanqing,Mao,Xinhua,et al.High-energy extracorporeal shock wave therapy for nontraumatic osteonecrosis of the femoral head.[J].Journal of orthopaedic surgery and research,2018,13(1):25.
[8] Zhao Wenyi,Gao Yuan,Zhang Shouxiang, et al. Extracorporeal shock wave therapy for bone marrow edema syndrome in patients with osteonecrosis of the femoral head: a retrospective cohort study.[J]. Journal of orthopaedic surgery and research,2021,161.
[9] Alkhawashki HM.Shock wave therapy of fracture nonunion.Injury2015;46(11):2248-52.
[10] Gao F,Sun W,Li Z,Guo W,et al.Extracorporeal shock wave therapy in the treatment of primary bone marrow edema syndrome of the knee: a prospective randomised controlled study.BMC Musculoskelet Disord.2015(11) 5;16:379.
[11] Yoon, BH, Mont, MA, Koo, KH, et al. The 2019 Revised Version of Association Research Circulation Osseous Staging System of Osteonecrosis of the Femoral Head. J ARTHROPLASTY. 2019; 35 (4): 933-940.
[12] Chen, JM, Hsu, SL, Wong, T, et al. Functional outcomes of bilateral hip necrosis: total hip arthroplasty versus extracorporeal shockwave. ARCH ORTHOP TRAUM SU. 2009; 129 (6): 837-41.
[13] van der Waal, JM, Terwee, CB, van der Windt, DA, et al. The impact of non-traumatic hip and knee disorders on health-related quality of life as measured with the SF-36 or SF-12. A systematic review. QUAL LIFE RES. 2005; 14 (4): 1141-55.
[14] Moya-Angeler J, Gianakos AL, Villa JC, Ni A, Lane JM. Current concepts on osteonecrosis of the femoral head. World J Orthop.2015;6:590–601.
[15] Mont M A, Jones L C, Hungerford D S. Nontraumatic osteonecrosis of the femoral head: Ten years later[J]. The Journal of Bone & Joint Surgery: American Volume, 2006,88(5):1117-1132.
[16] Chen C H, Wang G J. Alendronate in the prevention of collapse of the femoral head in non traumatic osteonecrosis[J]. Formosan Journal of Musculoskeletal Disorders, 2014,7 (3):138-144.
[17] Mei, J, Pang, L, Jiang, Z. The effect of extracorporeal shock wave on osteonecrosis of femoral head: a systematic review and meta-analysis. PHYSICIAN SPORTSMED. 2021; 50 (4): 280-288.
[18] Alkhawashki, HM, Al-Boukai, AA, Al-Harbi, MS, et al. The use of extracorporeal shock wave therapy (ESWT) in treating osteonecrosis of the femoral head (AVNFH): a retrospective study. INT ORTHOP. 2023; 47 (12): 2953-2960.
[19] Gao, F, Sun, W, Li, Z, et al. High-Energy Extracorporeal Shock Wave for Early Stage Osteonecrosis of the Femoral Head: A Single-Center Case Series. EVID-BASED COMPL ALT. 2015; 2015 468090.
[20] Yang, X, Shi, L, Zhang, T, et al. High-energy focused extracorporeal shock wave prevents the occurrence of glucocorticoid-induced osteonecrosis of the femoral head: A prospective randomized controlled trial. J ORTHOP TRANSL. 2022; 36 145-151.
[21] Zhao, W, Gao, Y, Zhang, S, et al. Extracorporeal shock wave therapy for bone marrow edema syndrome in patients with osteonecrosis of the femoral head: a retrospective cohort study. J Orthop Surg Res. 2021; 16 (1): 21.
[22] Patel, A, Dabhi, A, Chauhan, M. Effect of Extracorporeal Shock Wave Therapy in Osteonecrosis of Femoral Head of Hip in Patients on Pain and Function: An Evidence Based Study Int J Health Sci Res. 2022; 12 (12): 204-207.
[23] Cheng JH, Wang CJ. Biological mechanism of shockwave in bone.Int J Surg. 2015 Dec;24 (Pt:B):143–6.
[24] Zhai L, Sun N, Zhang B, et al. Effects of focused extracorporealshock waves on bone marrow mesenchymal stem cells in patientswith avascular necrosis of the femoral head. Ultrasound Med Biol.2016 Mar;42(3):753–762.
[25] Sansone V, Romeo P, Lavanga V. Extracorporeal shock wave therapy is effective in the treatment of bone marrow edema of the medial compartment of the knee: a comparative study [J]. Med Princ Pract,2017, 26(1): 23-29.
[26] Colvin G, Johnson M, Scifers JR, et al. Extracorporeal shockwave therapy [J]. Athletic Training and Sports Health Care, 2017, 9(5):200-202.
[27] Abe Y, Ito K, Hao K, Shindo T, Ogata T, Kagaya Y, et al. Extracorporeal low-energy shock-wave therapy exerts anti-inflammatory effects in a rat model of acute myocardial infarction. Circ J.2014;78:2915–2925.
[28] Ma, HZ, Zhou, DS, Li, D, et al. A histomorphometric study of necrotic femoral head in rabbits treated with extracorporeal shock waves. J PHYS THER SCI. 2017; 29 (1): 24-28.
How to Cite this article: Zhang L, Zhu X, Ling H, Duan R, Zhang Y, Liu Y, Chen X | High energy focused extracorporeal shock wave therapy for early and mid-stage femoral head necrosis: A single center retrospective cohort study | Journal of Regenerative Science | Jul-Dec 2023; 3(2): 29-34. |
Leave a Reply
Want to join the discussion?Feel free to contribute!